Skystar Bio (SKBI) Purchased Aquaculture Vaccine Technology and Signs Collaborative R&D with China's Fourth MMU

December 9, 2009 7:06 AM EST Send to a Friend
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) today announced that it has purchased an exclusive aquaculture vaccine technology from and signed a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login